The Drosophila metabotropic glutamate receptor DmGluRA regulates activity-dependent synaptic facilitation and fine synaptic morphology

被引:69
作者
Bogdanik, L
Mohrmann, R
Ramaekers, A
Bockaert, J
Grau, Y
Broadie, K
Parmentier, ML
机构
[1] CNRS, Unite Propre Rech 2580, Lab Genom Fonct, F-34094 Montpellier 05, France
[2] Vanderbilt Univ, Vanderbilt Brain Inst, Kennedy Ctr Res Human Dev, Dept Biol Sci, Nashville, TN 37232 USA
关键词
G-protein-coupled receptor; neuromuscular junction; presynaptic; bouton; excitability; synaptic modulation; facilitation; augmentation;
D O I
10.1523/JNEUROSCI.2724-04.2004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In vertebrates, several groups of metabotropic glutamate receptors (mGluRs) are known to modulate synaptic properties. In contrast, the Drosophila genome encodes a single functional mGluR (DmGluRA), an ortholog of vertebrate group II mGluRs, greatly expediting the functional characterization of mGluR-mediated signaling in the nervous system. We show here that DmGluRA is expressed at the glutamatergic neuromuscular junction (NMJ), localized in periactive zones of presynaptic boutons but excluded from active sites. Null DmGluRA mutants are completely viable, and all of the basal NMJ synaptic transmission properties are normal. In contrast, DmGluRA mutants display approximately a threefold increase in synaptic facilitation during short stimulus trains. Prolonged stimulus trains result in very strongly increased ( similar to 10-fold) augmentation, including the appearance of asynchronous, bursting excitatory currents never observed in wild type. Both defects are rescued by expression of DmGluRA only in the neurons, indicating a specific presynaptic requirement. These phenotypes are reminiscent of hyperexcitable mutants, suggesting a role of DmGluRA signaling in the regulation of presynaptic excitability properties. The mutant phenotypes could not be replicated by acute application of mGluR antagonists, suggesting that DmGluRA regulates the development of presynaptic properties rather than directly controlling short-term modulation. DmGluRA mutants also display mild defects in NMJ architecture: a decreased number of synaptic boutons accompanied by an increase in mean bouton size. These morphological changes bidirectionally correlate with DmGluRA levels in the presynaptic terminal. These data reveal the following two roles for DmGluRA in presynaptic mechanisms: ( 1) modulation of presynaptic excitability properties important for the control of activity-dependent neurotransmitter release and ( 2) modulation of synaptic architecture.
引用
收藏
页码:9105 / 9116
页数:12
相关论文
共 67 条
[11]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[12]   Physiological roles and therapeutic potential of metabotropic glutamate receptors [J].
Conn, PJ .
GLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION, 2003, 1003 :12-21
[13]   Characterization of sequences associated with position-effect variegation at pericentric sites in Drosophila heterochromatin [J].
Cryderman, DE ;
Cuaycong, MH ;
Elgin, SCR ;
Wallrath, LL .
CHROMOSOMA, 1998, 107 (05) :277-285
[14]   Genetic analysis of synaptic development and plasticity: homeostatic regulation of synaptic efficacy [J].
Davis, GW ;
Goodman, CS .
CURRENT OPINION IN NEUROBIOLOGY, 1998, 8 (01) :149-156
[15]  
DELCASTILLO J, 1954, J PHYSIOL-LONDON, V126, pP27
[16]  
DiAntonio A, 1999, J NEUROSCI, V19, P3023
[17]   Progression of change in NMDA, non-NMDA, and metabotropic glutamate receptor function at the developing corticothalamic synapse [J].
Golshani, P ;
Warren, RA ;
Jones, EG .
JOURNAL OF NEUROPHYSIOLOGY, 1998, 80 (01) :143-154
[18]   Role of Drosophila alpha-adaptin in presynaptic vesicle recycling [J].
GonzalezGaitan, M ;
Jackle, H .
CELL, 1997, 88 (06) :767-776
[19]  
Hou DM, 2003, J NEUROSCI, V23, P5897
[20]   LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors [J].
Kingston, AE ;
Ornstein, PL ;
Wright, RA ;
Johnson, BG ;
Mayne, NG ;
Burnett, JP ;
Belagaje, R ;
Wu, S ;
Schoepp, DD .
NEUROPHARMACOLOGY, 1998, 37 (01) :1-12